Home > Insider Trading > Filing (0001209191-21-071172)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
818033	Heron Therapeutics Inc.	HRTX	Pharmaceutical Preparations (2834)	942875566

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1553179	Waage Christian	4242 Campus Point Court Suite 200 San Diego CA 92121		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2021-12-21	300	$9.73	3,200	No	4	S	Direct
Common Stock	Acquisiton	2021-12-22	10,452	$0.00	13,652	No	4	A	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	A	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Acquisiton	2021-12-22	20,903	$0.00	20,903	$9.81

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
20,903		2031-12-22	No	4	A	Direct

Footnotes

The sale of common stock reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan dated as of March 15, 2021. The shares were sold by Mr. Waage to cover his estimated tax liability associated with the vesting of 750 restricted stock units (RSUs) on December 21, 2021.
The range of sales prices received was $9.625 to $9.945. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information will be provided regarding the number of shares purchased or sold at each separate price.
The shares were granted as restricted stock units which vest in full on December 22, 2022.
The stock options vest and become exercisable in 12 equal monthly installments beginning one month after the date of grant.